Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
05/22/2008 | WO2008028805A3 Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections |
05/22/2008 | WO2008023004A8 Single enantiomer beta agonists method for production and use thereof as a medicament |
05/22/2008 | WO2008023003A8 Drug combinations for treating airway diseases |
05/22/2008 | WO2007100560A3 Use of dha and ara in the preparation of a composition for inducing the expression of pulmonary surfactant protein-b |
05/22/2008 | US20080119564 evalbuterol L-hemitartrate, a crystal form; administered using a metered dose inhaler containg an aerosol in crystal form to effect bronchodilation; reproducible; stablility; storage stability; aerodynamically favorable shape, such as a fiber, to reach lung depth; antiagglomerants |
05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
05/22/2008 | US20080119487 Novel non-imidazole compounds |
05/22/2008 | US20080119469 Novel Compounds |
05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
05/22/2008 | US20080119462 Method for treating vascular hyperpermeable disease |
05/22/2008 | US20080119428 Method For Diagnosing Non-Small Cell Lung Cancers By Trna-Dihydrouridine Synthase Activity Of Urlc8 |
05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
05/22/2008 | US20080118571 Modified release analgesic suspensions |
05/22/2008 | US20080118566 Micronizing mometasone furoate and lactose particles, wherein at least one has a convertible amorphous content, homogenizing, agglomerating, converting the amorphous to crystalline |
05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
05/22/2008 | US20080118473 Methods of treating a respiratory condition comprising probiotic treatment |
05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
05/22/2008 | CA2669395A1 Crystalline form of tiotropium bromide and urea |
05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
05/22/2008 | CA2666903A1 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
05/22/2008 | CA2665808A1 Ccr2 antagonists for treatment of fibrosis |
05/21/2008 | EP1923393A1 Crystalline form of tiotropium bromide and urea |
05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
05/21/2008 | EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
05/21/2008 | EP1923066A1 Composition comprising rooibos tea and conjugated linoleic acid (CLA) |
05/21/2008 | EP1922318A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
05/21/2008 | EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists |
05/21/2008 | EP1922312A1 Thiazole compounds and their use as pgd2 antagonists |
05/21/2008 | EP1922305A1 New salt ii |
05/21/2008 | EP1922081A2 Interferon lambda therapy for treatment of respiratory diseases |
05/21/2008 | EP1922076A2 Use of lipid conjugates in cystic fibrosis and applications thereof |
05/21/2008 | EP1922074A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma. |
05/21/2008 | EP1922073A1 New capped pyrazinoylguanidine sodium channel blockers |
05/21/2008 | EP1922070A1 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
05/21/2008 | EP1284740B1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with monosaccharide-based compounds |
05/21/2008 | CN101184729A Inhibitors of cytosolic phospholipase a2 |
05/21/2008 | CN101184725A N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
05/21/2008 | CN101184484A Novel use of organic compounds |
05/21/2008 | CN101181625A Chinese medicine prescription for rhinitis as well as preparation method thereof |
05/21/2008 | CN101181620A Pharmaceutical combination for curing chronic bronchitis and bronchial asthma as well as preparation method |
05/21/2008 | CN101181596A Chinese medicine composition orally taken for curing bronchiolectasis |
05/21/2008 | CN101181563A Chrysoidine productive cough preparations as well as preparation method and mass control method |
05/21/2008 | CN101181562A Mass control method of fructus momordicae compound preparations |
05/21/2008 | CN101181561A Chinese medicine as well as preparation method and application thereof |
05/21/2008 | CN101181558A Chinese medicine composition orally taken for curing bronchiolectasis |
05/21/2008 | CN101181556A Chinese medicine prescription orally taken for curing chronic bronchitis |
05/21/2008 | CN101181553A Chinese medicine prescription for common cold as well as preparation method thereof |
05/21/2008 | CN101181543A Chinese medicine composition orally taken for curing chronic bronchitis |
05/21/2008 | CN101181527A Chinese medicine composition orally taken for curing acute tonsillitis |
05/21/2008 | CN101181523A Chinese medicine prescription orally taken for curing bronchiolectasis |
05/21/2008 | CN101181517A Chinese medicine medicinal granules for tonifying lung and relieving cough |
05/21/2008 | CN101181513A Medicament for curing lung and laryngopharynx disease as well as producing method thereof |
05/21/2008 | CN101181510A Chinese medicine composition orally taken for curing pulmonary emphysema |
05/21/2008 | CN101181509A Chinese medicine prescription orally taken for curing pulmonary emphysema |
05/21/2008 | CN101181503A Chinese medicine prescription orally taken for curing chronic bronchitis |
05/21/2008 | CN101181502A Chinese medicine composition orally taken for curing chronic bronchitis |
05/21/2008 | CN101181501A Chinese medicine decoction for curing sinusitis |
05/21/2008 | CN101181500A Externally used medicament for curing respiratory system disease and preparation method thereof |
05/21/2008 | CN101181497A Quietus powder |
05/21/2008 | CN101181496A Medicament for preventing and controlling infectious bronchitis |
05/21/2008 | CN101181495A Prescription with ringing function and uses thereof |
05/21/2008 | CN101181494A Chinese medicine composition orally taken for curing bronchial asthma |
05/21/2008 | CN101181479A Technique for extracting reineckea carnea total saponin |
05/21/2008 | CN101181478A Chinese medicine for curing lung cancer and mammary cancer |
05/21/2008 | CN101181465A Chinese medicine prescription orally taken for curing pneumatosis pulmonum |
05/21/2008 | CN101181442A Chinese medicine composition orally taken for curing asthma |
05/21/2008 | CN101181437A Chinese medicine composition orally taken for curing acute tonsillitis |
05/21/2008 | CN101181415A Chinese medicine decoction for curing chronic sinusitis |
05/21/2008 | CN101181408A Chinese medicine composition for the oral medication of chronic sinusitis |
05/21/2008 | CN101181407A Oral cavity medicine for curing chronic pharyngitis |
05/21/2008 | CN101181404A Buccal tablets for curing pharynx sickness as well as preparation method |
05/21/2008 | CN101181392A Chinese medicine prescription orally taken for curing allergic rhinitis |
05/21/2008 | CN101181388A Mass control method of keke oral preparation |
05/21/2008 | CN101181365A Chinese medicine composition orally taken for curing tonsillitis |
05/21/2008 | CN101181358A Santanning dropping pills and preparation method thereof |
05/21/2008 | CN101181357A Mass control method of ketelin lozenge |
05/21/2008 | CN101181352A Chinese medicine preparation for curing acute rhinitis and preparation method thereof |
05/21/2008 | CN101181343A Mass control method of rhinitis tablet of climbing groundsel and spikemoss |
05/21/2008 | CN101181332A Chinese medicine oral liquid for curing chronic trachitis and its manufacturing method |
05/21/2008 | CN101181320A Dyer's woad root vitamin C fizzy formulation |
05/21/2008 | CN101181319A Chinese medicine and mass control method of preparations thereof |
05/21/2008 | CN101181312A Method for preparing korean pine cone extract |
05/21/2008 | CN101181274A Pharmaceutical composition taking cefixime and erdosteine as active component as well as preparation method and usage thereof |
05/21/2008 | CN101181263A Treatment of respiratory diseases |
05/21/2008 | CN101180999A Mixed mode donglinqingyan fire-dropping tea and preparation method thereof |
05/21/2008 | CN100389120C Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
05/21/2008 | CN100388943C Medicine for treating cough and bronchitis |
05/21/2008 | CN100388939C Chinese medicine for treating chronic bronchitis |
05/21/2008 | CN100388933C Quality control method of child cough and panting preparation |
05/21/2008 | CN100388926C Method for quality control of oral prepn. contg. isatis root |
05/21/2008 | CN100388922C Chinese medicinal preparation for treating sorethroat, aphtha and its preparation method |
05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
05/20/2008 | US7375205 Elongase genes and uses thereof |
05/20/2008 | US7375202 Human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
05/20/2008 | US7375131 NF-κB inhibitors |
05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |